American Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Sell
2,250,878
-73,488
-3% -$773K 0.9% 34
2025
Q4
$27.3M Sell
2,324,366
-20,897
-0.9% -$225K 1.21% 32
2025
Q3
$18.1M Buy
2,345,263
+1,283,390
+121% +$8.99M 0.72% 36
2025
Q2
$7.76M Buy
1,061,873
+980,811
+1,210% +$7.92M 0.32% 43
2025
Q1
$769K Buy
+81,062
New +$1.01M 0.03% 59
2022
Q2
Sell
-12,376
Closed -$150K 66
2022
Q1
$150K Sell
12,376
-214,328
-95% -$4.51M ﹤0.01% 65
2021
Q4
$7.74M Sell
226,704
-10,619
-4% -$416K 0.2% 49
2021
Q3
$11.4M Buy
237,323
+732
+0.3% +$33.9K 0.31% 47
2021
Q2
$10.7M Buy
236,591
+1,723
+0.7% +$76.3K 0.3% 48
2021
Q1
$11.3M Sell
234,868
-38,232
-14% -$1.99M 0.34% 51
2020
Q4
$14.7M Sell
273,100
-1,735
-0.6% -$78.4K 0.44% 44
2020
Q3
$10.1M Buy
274,835
+5,630
+2% +$209K 0.37% 45
2020
Q2
$8.34M Buy
269,205
+229,966
+586% +$6.37M 0.31% 48
2020
Q1
$1.08M Sell
39,239
-9,331
-19% -$280K 0.05% 63
2019
Q4
$1.42M Hold
48,570
0.06% 61
2019
Q3
$929K Sell
48,570
-20
-0% -$469 0.04% 64
2019
Q2
$1.07M Sell
48,590
-1,735
-3% -$38.1K 0.05% 65
2019
Q1
$1.03M Buy
50,325
+11,075
+28% +$192K 0.05% 64
2018
Q4
$495K Buy
+39,250
New +$585K 0.03% 69

Other funds holding NEO

American Capital Management's NEO Position: Q1 2026 in Review

American Capital Management reduced its NeoGenomics (NEO) stake by 3.2% in Q1 2026, selling an estimated $773K and leaving 2,250,878 shares worth $16.7M. The position accounts for 0.9% of the portfolio, ranked #34.

American Capital Management first reported a position in NEO in Q4 2018 and has held it in 19 quarters since. The position peaked at $27.3M in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • American Capital Management held 2,250,878 shares of NeoGenomics worth $16.7M as of Q1 2026.
  • American Capital Management sold 73,488 NeoGenomics shares in Q1 2026, an estimated $773K.
  • NeoGenomics made up 0.9% of American Capital Management's portfolio in Q1 2026, its #34 holding.
  • American Capital Management first reported a position in NeoGenomics in Q4 2018 and has held it in 19 quarters since.
  • American Capital Management's NeoGenomics position peaked at $27.3M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on American Capital Management's 13F filing for Q1 2026, filed 15 May 2026.